Keywords: fda, approves, novartis, zelnorm, constipation-predominant, ibs, women

US FDA approves Novartis' Zelnorm for constipation-predominant IBS in women

Article | 05 August 2002

Print This

Novartis' Zelnorm (tegaserod maleate) has become the first and onlyprescription drug approved by the US Food and Drug Administration for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in